Food and Drug Administration advisers on Friday unanimously voted in favor of a highly anticipated hepatitis C drug from Gilead Sciences that holds promise for millions of Americans infected with the liver-destroying virus.
http://www.siliconvalley.com/news/ci_24388528/gilead-hepatitis-c-drug-backed-unanimously-by-fda
http://www.siliconvalley.com/news/ci_24388528/gilead-hepatitis-c-drug-backed-unanimously-by-fda
No comments:
Post a Comment